Hjem › Orofaryngeal kreft › Texas › Houston
Kliniske studier for Orofaryngeal kreft i Houston, TX
5 studier for Orofaryngeal kreft søker deltakere på steder i og rundt Houston (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Rekrutterer
- M D Anderson Cancer Center, Houston
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
RekruttererFase 3
- UT MD Anderson Cancer Center, Houston
- UT MD Anderson - West Houston, Houston
High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors
RekruttererFase 1/2
- M D Anderson Cancer Center, Houston
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
RekruttererObservasjonsstudie
- M D Anderson Cancer Center, Houston
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Rekrutterer
- Baylor College of Medicine, Houston
Orofaryngeal kreft-studier i andre byer
- Atlanta, GA8 studier
- Edison, NJ8 studier
- Chicago, IL7 studier
- New York City, NY6 studier
- Queens, NY5 studier
- St. Louis, MO5 studier
- Tampa, FL5 studier
- Kansas City, MO5 studier
- Philadelphia, PA5 studier
- Omaha, NE5 studier
- Los Angeles, CA5 studier
- Pittsburgh, PA5 studier
Andre studier i Houston
- Ikke-småcellet lungekreft145 studier
- Brystkreft126 studier
- Kreft (alle typer)121 studier
- Metastatisk kreft104 studier
- Kolorektal kreft102 studier
- Eggstokkreft89 studier
- Akut myelogen leukemi85 studier
- Lungekreft78 studier
- Prostatakreft76 studier
- Endometriekreft68 studier
- Pankreaskreft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.